R Sprengelmeyer1, M Orth1, H-P Müller1, R C Wolf2, G Grön3, M S Depping2, J Kassubek1, D Justo4, E M Rees5, S Haider5, J H Cole5, N Z Hobbs5, R A C Roos6, A Dürr4, S J Tabrizi5, S D Süssmuth1, G B Landwehrmeyer1. 1. Department of Neurology,University of Ulm,Ulm,Germany. 2. Centre for Psychosocial Medicine, Department of General Psychiatry,University of Heidelberg,Heidelberg,Germany. 3. Department of Psychiatry,University of Ulm,Ulm,Germany. 4. Institut du Cerveau et de la Moelle épinière, Pitié-Salpêtrière Hospital,Pierre and Marie Curie University (UPMC),Paris,France. 5. Department of Neurodegenerative Disease, Institute of Neurology,University College London,London,UK. 6. Department of Neurology,Leiden University Medical Centre,Leiden,The Netherlands.
Abstract
BACKGROUND: Depressive symptoms are prominent psychopathological features of Huntington's disease (HD), making a negative impact on social functioning and well-being. METHOD: We compared the frequencies of a history of depression, previous suicide attempts and current subthreshold depression between 61 early-stage HD participants and 40 matched controls. The HD group was then split based on the overall HD group's median Hospital Anxiety and Depression Scale-depression score into a group of 30 non-depressed participants (mean 0.8, s.d. = 0.7) and a group of 31 participants with subthreshold depressive symptoms (mean 7.3, s.d. = 3.5) to explore the neuroanatomy underlying subthreshold depressive symptoms in HD using voxel-based morphometry (VBM) and diffusion tensor imaging (DTI). RESULTS: Frequencies of history of depression, previous suicide attempts or current subthreshold depressive symptoms were higher in HD than in controls. The severity of current depressive symptoms was also higher in HD, but not associated with the severity of HD motor signs or disease burden. Compared with the non-depressed HD group DTI revealed lower fractional anisotropy (FA) values in the frontal cortex, anterior cingulate cortex, insula and cerebellum of the HD group with subthreshold depressive symptoms. In contrast, VBM measures were similar in both HD groups. A history of depression, the severity of HD motor signs or disease burden did not correlate with FA values of these regions. CONCLUSIONS: Current subthreshold depressive symptoms in early HD are associated with microstructural changes - without concomitant brain volume loss - in brain regions known to be involved in major depressive disorder, but not those typically associated with HD pathology.
BACKGROUND: Depressive symptoms are prominent psychopathological features of Huntington's disease (HD), making a negative impact on social functioning and well-being. METHOD: We compared the frequencies of a history of depression, previous suicide attempts and current subthreshold depression between 61 early-stage HD participants and 40 matched controls. The HD group was then split based on the overall HD group's median Hospital Anxiety and Depression Scale-depression score into a group of 30 non-depressed participants (mean 0.8, s.d. = 0.7) and a group of 31 participants with subthreshold depressive symptoms (mean 7.3, s.d. = 3.5) to explore the neuroanatomy underlying subthreshold depressive symptoms in HD using voxel-based morphometry (VBM) and diffusion tensor imaging (DTI). RESULTS: Frequencies of history of depression, previous suicide attempts or current subthreshold depressive symptoms were higher in HD than in controls. The severity of current depressive symptoms was also higher in HD, but not associated with the severity of HD motor signs or disease burden. Compared with the non-depressed HD group DTI revealed lower fractional anisotropy (FA) values in the frontal cortex, anterior cingulate cortex, insula and cerebellum of the HD group with subthreshold depressive symptoms. In contrast, VBM measures were similar in both HD groups. A history of depression, the severity of HD motor signs or disease burden did not correlate with FA values of these regions. CONCLUSIONS: Current subthreshold depressive symptoms in early HD are associated with microstructural changes - without concomitant brain volume loss - in brain regions known to be involved in major depressive disorder, but not those typically associated with HD pathology.
Authors: Costanza Ferrari Bardile; Marta Garcia-Miralles; Nicholas S Caron; Nirmala Arul Rayan; Sarah R Langley; Nathan Harmston; Ana Maria Rondelli; Roy Tang Yi Teo; Sabine Waltl; Lisa M Anderson; Han-Gyu Bae; Sangyong Jung; Anna Williams; Shyam Prabhakar; Enrico Petretto; Michael R Hayden; Mahmoud A Pouladi Journal: Proc Natl Acad Sci U S A Date: 2019-04-23 Impact factor: 11.205
Authors: Hans-Peter Müller; Martin Gorges; Georg Grön; Jan Kassubek; G Bernhard Landwehrmeyer; Sigurd D Süßmuth; Robert Christian Wolf; Michael Orth Journal: J Neurol Date: 2016-01-13 Impact factor: 4.849
Authors: Peter McColgan; Adeel Razi; Sarah Gregory; Kiran K Seunarine; Alexandra Durr; Raymund A C Roos; Blair R Leavitt; Rachael I Scahill; Chris A Clark; Doug R Langbehn; Geraint Rees; Sarah J Tabrizi Journal: Hum Brain Mapp Date: 2017-03-15 Impact factor: 5.038
Authors: Sarah Gregory; Rachael I Scahill; Kiran K Seunarine; Cheryl Stopford; Hui Zhang; Jiaying Zhang; Michael Orth; Alexandra Durr; Raymund A C Roos; Douglas R Langbehn; Jeffrey D Long; Hans Johnson; Geraint Rees; Sarah J Tabrizi; David Craufurd Journal: J Huntingtons Dis Date: 2015
Authors: Roy Tang Yi Teo; Xin Hong; Libo Yu-Taeger; Yihui Huang; Liang Juin Tan; Yuanyun Xie; Xuan Vinh To; Ling Guo; Reshmi Rajendran; Arianna Novati; Carsten Calaminus; Olaf Riess; Michael R Hayden; Huu P Nguyen; Kai-Hsiang Chuang; Mahmoud A Pouladi Journal: Hum Mol Genet Date: 2016-04-28 Impact factor: 6.150